Physician profile
Peter Olberding
NPI 1457443913
$5,379.22
in general payments reported to CMS, 2019-2025
11 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what 98% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $317 · 2021: $83.12 · 2022: $476 · 2023: $57.28 · 2024: $2,146 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,565 · Food and Beverage: $1,153 · Gift: $1,095 · Entertainment: $64.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,564.53 |
| Food and Beverage | $1,152.61 |
| Gift | $1,095.00 |
| Entertainment | $64.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $1,610.00 | 2019-2024 | |
| Patterson Companies, INC. | $1,548.12 | 2022-2025 | |
| Dentsply Sirona INC | $1,045.71 | 2024-2025 | Cerec |
| Align Technology, INC. | $396.60 | 2020-2025 | Invisalign, Invisalign Express 10, Itero Element 2 Plus |
| Straumann USA LLC | $390.59 | 2022-2025 | |
| Scican INC | $154.00 | 2020 | |
| Henry Schein, INC. | $110.91 | 2019 | |
| Septodont INC. | $72.93 | 2020 | |
| Ultradent Products INC | $24.50 | 2024 | |
| Gc America INC. | $13.11 | 2024 | Equia, G-Aenial, G-Premio Bond |
| Kerr Corporation | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Olberding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.